context of the provision of health care services for cancer patients, the quality of care is likely to be at least as important to patients as the price. Accordingly, defendants’ claim that plaintiffs have failed to allege market-wide injury is rejected, b. Failure to Adequately Allege Causation Defendants further argue that plaintiffs have failed to demonstrate that defendants’ actions, even if anticompetitive, have caused plaintiffs’ injuries. Again, defendants’ argument fails. Defendants argue that, as owners and operators of radiology facilities, they are not competitors of Medscan. First, there is no requirement that a plaintiff be a consumer or competitor to assert an antitrust claim. See Blue Shield of Va. v. McCready, 457 U.S. 465, 483-84, 102 S.Ct. 2540, 73 L.Ed.2d 149 (1982) (<HOLDING>). Second, defendants’ definition of the
holding that injury to broker through loss of commission was not antitrust injury holding that an antitrust injury is an injury that is attributable to an anticompetitive aspect of the practice under scrutiny holding that noncompetitors injury was an antitrust injury as it was inextricably intertwined with the injury the conspirators sought to inflict holding that an antitrust injury is a necessary element of a  2 claim holding that plaintiff must show antitrust injury meaning injury of the type the antitrust laws were intended to prevent and which flows from defendants unlawful acts